These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
US takes next step in Medicare drug price negotiations with pharma companies
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Roivant's anti-inflammatory drug succeeds in mid-stage study
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Column: Conservative groups object to 'naming names' rule from Pfizer diversity decision
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
2 Stocks Down 30% and 27% to Buy and Hold
US scientists are leaving academia. That’s bad news for drug companies
5 FDA decisions to watch in the second quarter
Better Recovery Story Buy: Pfizer vs Moderna
Cramer's Lightning Round: Leidos is a winner
US CDC alerts healthcare providers of increase in meningococcal disease
20 Best Stocks to Buy Right Now According to Financial Media
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.